News & Updates

Are we winning the fight against COVID-19?

08 Sep 2020 by

Eight months into the pandemic, the world is still in the heat of fighting a contagion that we’ve no treatment for and no protection from. So far, what we’re able to achieve is a stalemate against COVID-19. Science remains our best hope – a vaccine against SARS-COV-2 with long-lasting protection.

Are we winning the fight against COVID-19?

08 Sep 2020

Oral masitinib helps for severe asthma uncontrolled on steroids

08 Sep 2020 by

The first-in-class tyrosine kinase inhibitor masitinib significantly reduces severe asthma exacerbations in patients who are uncontrolled on oral corticosteroids (OCS), regardless of their baseline eosinophil counts, according to a study presented at the ATS 2020 Virtual Meeting.

Oral masitinib helps for severe asthma uncontrolled on steroids

08 Sep 2020

Junior residents need more exposure to manage obstetric airway

08 Sep 2020 by

The local incidence of difficult intubation of patients delivering by caesarean section under general anaesthesia at a high-volume obstetric hospital in Singapore is 33 in 660 (1:20 or 5.0 percent), reports a recent study. No case of failed intubation has been recorded.

Junior residents need more exposure to manage obstetric airway

08 Sep 2020

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

07 Sep 2020 by

A small study conducted in Iran suggests a role for sofosbuvir-daclatasvir in the treatment of moderate-to-severe COVID-19.

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

07 Sep 2020

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020 by

Interim analyses of the INBUILD trial presented at ATS 2020 continue to reflect the benefit of the tyrosine kinase inhibitor nintedanib for individuals with progressive fibrosing interstitial lung diseases (ILDs).

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020

Flavoured cigarette ban helps reduce smoking in youths

03 Sep 2020

A ban on flavoured cigarettes is an effective measure to curb cigarette use among young people, a recent study has found.

Flavoured cigarette ban helps reduce smoking in youths

03 Sep 2020

How real is the airborne threat of COVID-19?

28 Aug 2020 by

After months of debate on whether COVID-19 can spread via airborne route, mounting evidence suggests that this is indeed the case — particularly in enclosed areas.

How real is the airborne threat of COVID-19?

28 Aug 2020

Apnoea or habitual long sleep doubles AD risk

28 Aug 2020 by

Having sleep apnoea or sleeping more than 9 hours every night doubles the risk of developing Alzheimer’s disease (AD) in middle-aged individuals within 6 years in a new study.

Apnoea or habitual long sleep doubles AD risk

28 Aug 2020

High BP may raise risk of dying from COVID-19

27 Aug 2020 by

Hypertensive patients are twice more likely to die from COVID-19 — particularly if they are not treated with antihypertensive medications — than people without hypertension, a large retrospective study has shown.

High BP may raise risk of dying from COVID-19

27 Aug 2020

ORF8 and ORF3b antibodies: Highly sensitive and specific new markers for early and late SARS-CoV-2 infection

27 Aug 2020 by

Hong Kong and French researchers have assessed antibody responses to a panel of 15 severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigens, identifying and further validating antibodies to open reading frame (ORF)8 and ORF3b within the virus’s RNA as accurate serological markers of early and late SARS-CoV-2 infection.

ORF8 and ORF3b antibodies: Highly sensitive and specific new markers for early and late SARS-CoV-2 infection

27 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Are we winning the fight against COVID-19?

Are we winning the fight against COVID-19?

Oral masitinib helps for severe asthma uncontrolled on steroids

Oral masitinib helps for severe asthma uncontrolled on steroids

Junior residents need more exposure to manage obstetric airway

Junior residents need more exposure to manage obstetric airway

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

Nintedanib continues to show promise for progressive fibrosing ILDs

Nintedanib continues to show promise for progressive fibrosing ILDs

Flavoured cigarette ban helps reduce smoking in youths

Flavoured cigarette ban helps reduce smoking in youths

How real is the airborne threat of COVID-19?

How real is the airborne threat of COVID-19?

Apnoea or habitual long sleep doubles AD risk

Apnoea or habitual long sleep doubles AD risk

High BP may raise risk of dying from COVID-19

High BP may raise risk of dying from COVID-19

ORF8 and ORF3b antibodies: Highly sensitive and specific new markers for early and late SARS-CoV-2 infection

ORF8 and ORF3b antibodies: Highly sensitive and specific new markers for early and late SARS-CoV-2 infection